- General Dermatology
- Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
PODCAST: Incentives to encourage adherence, part 4
In this last part of our discussion on patient adherence, Dermatology Times editorial adviser, Elaine Siegfried, M.D., continues the discussion with Steven Feldman, M.D., on assessing adherence and intervening to encourage the best possible treatment outcomes.
In this last part of our discussion on patient adherence, Dermatology Times editorial adviser, Elaine Siegfried, M.D., continues the discussion with Steven Feldman, M.D., on assessing adherence and intervening to encourage the best possible treatment outcomes. They discuss a method for developing patient accountability, clinical trial results versus real life, and whole health system incentives for focusing more research in this area. Dr. Feldman is a professor of dermatology at the Wake Forest University School of Medicine, Winston-Salem, N.C.
Listen to more in this series:
The importance of patient adherence, part 1
Positively influence patient adherence, part 2
Using surveys to improve patient relations, part 3
